Financial Year |
March 31 2023 |
Monetary Funds |
6,976,230,302.63 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
169,333,887.87 |
Accounts Receivable |
2,164,881,380.53 |
Advances to Suppliers |
1,370,672,867.18 |
Other Receivables |
342,114,959.33 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
6,131,193.58 |
Dividend Receivable |
-- |
Inventories |
4,264,217,338.94 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
703,182,893.94 |
Total Current Assets |
17,123,370,519.21 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,632,373,579.65 |
Investment Properties |
-- |
Fixed Assetes |
31,831,787,152.41 |
Under-construction Projects |
1,908,378,645.97 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
6,435,790,379.89 |
R&D expenses |
-- |
Goodwill |
384,653,251.92 |
Long-Term Deferred and Prepaid Expenses |
1,537,330,017.69 |
Deferred Income Tax Assets |
965,754,726.32 |
Other Non-Current Assets |
92,869,326.00 |
Sub-Total of Non-Current Assets |
45,851,529,017.55 |
Total Assets |
62,974,899,536.76 |
Short-Term Loans |
3,600,660,016.32 |
Trading Financial liabilities |
-- |
Notes Payable |
287,844,379.85 |
Accounts Payable |
4,643,479,729.74 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
46,613,841.91 |
Taxes Payable |
308,587,600.57 |
Interest Payable |
123,959,267.52 |
Dividend Payable |
786,584.83 |
Other payables |
1,250,869,779.24 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,822,045,163.90 |
Other Current Liabilities |
323,324,043.81 |
Sub-Total of Current Liabilities |
15,265,537,553.30 |
Long-term Loans |
7,257,388,500.00 |
Bonds Payable |
7,025,443,442.90 |
Long-Term Accounts Payable |
424,531,633.44 |
Special Payable |
-- |
Estimatied Liabilities |
429,393,493.70 |
Deferred Income Tax Liabilities |
198,645,181.45 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
15,985,915,097.08 |
Total Liabilities |
31,251,452,650.38 |
Paid-In Capital(Or Share Stock) |
2,658,214,254.00 |
Capital Surplus |
17,257,043,191.20 |
Surplus Reserve |
1,401,286,406.97 |
LESS:Treasury Stock |
279,344,753.96 |
Undistributed Profits |
8,772,118,412.05 |
Minority Stockholder's Interest |
1,815,598,710.36 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,907,848,176.02 |
Owner's Equity(Stockholder's Equity) |
31,723,446,886.38 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
62,974,899,536.76 |